EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Armodafinil in Milk

Philip O Anderson iD

Journal of Human Lactation · 2023

DOI: 10.1177/08903344231156361 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Human Lactation, 2023. Verfasst von Philip O Anderson. Hauptthemen laut MEDLINE: Milk, Central Nervous System Stimulants. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, I was pleased to see the article that provided more information on modafinil excretion into breastmilk (Leggett et al., 2022). However, I have some comments and questions. If only armodafinil was measured by the assay as stated in the paper, then the maternal dosage used to calculate the Relative Infant Dose (RID) should be 200 mg/day rather than 400 mg/ day, because modafinil is only 50% armodafinil and the other 50% is S-modafinil. When a maternal dose of 200 mg is used to calculate the RID, the RID would be twice as high as reported, that is, 9.7% rather than 4.85%. The two modafinil isomers have similar pharmacological activities, but S-modafinil exposure is about 25% of the total exposure at steady-state, according to the United States product information. This is a small, but not negligible amount. If only armodafinil was measured, the AUC, average concentration and the theoretical infant dose of active drug would be about 25% higher because S-modafinil would be present but undetected in maternal serum and likely in milk. The RID could be as high as about 12%, which is above the hypothetical 10% value of concern. Additionally, the authors calculated a milk/plasma ratio for armodafinil using a single maternal serum concentration. Milk/plasma ratio should be calculated using the area under the curve (AUC) values for both maternal serum and milk values (Wilson, 1985). Calculation using a single time point is subject to serious error unless there is little fluctuation in maternal plasma and milk levels, which is not the case in this report, or maternal serum and milk levels rise and fall in parallel, which is unknown. It is laudable that an infant plasma sample was taken at about 2 hours after the mother’s morning dose, but the nursing history before this time point is not stated, so it is difficult to know if this infant plasma level represents a trough level (if there was no milk intake after the mother’s morning dose), or if it reflects the level of the drug in the milk at some point between the morning dose and sampling time (Anderson, 2022). I look forward to the authors’ comments on the above points.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MilkCentral Nervous System StimulantsFemaleHumansAnimalsModafinilBreast FeedingPsychiatric Status Rating ScalesBenzhydryl CompoundsDouble-Blind MethodTreatment Outcome

Substanzen

ModafinilBenzhydryl CompoundsCentral Nervous System Stimulants

Autor:innen und Institutionen

ORCID-Profile: Philip O Anderson

Zitieren

APA

Anderson, P. O. (2023). Armodafinil in Milk. Journal of Human Lactation. https://doi.org/10.1177/08903344231156361

Vancouver

Anderson PO. Armodafinil in Milk. Journal of Human Lactation. 2023. doi:10.1177/08903344231156361

BibTeX
@article{Anderson2023,
  author = {Anderson, Philip O},
  title = {Armodafinil in Milk},
  journal = {Journal of Human Lactation},
  year = {2023},
  doi = {10.1177/08903344231156361}
}
Kostenlos starten →